Prognostic role of sarcopenia on major adverse cardiac events among patients who underwent successful percutaneous coronary intervention: A retrospective cohort study.

Expanding knowledge of sarcopenia among cardiovascular nurses may aid in early recognition of patients at risk of sarcopenia. Our finding implies that the sarcopenia index based on serum creatinine and cystatin C may be available as a prognostic factor for MACE in patients undergoing PCI. Future studies should be conducted to prospectively validate the sarcopenia index with a multicenter, large sample.